Published on 20 Mar 2024 on GuruFocus.com via Yahoo Finance

Insider Sell: Rhythm Pharmaceuticals Inc (RYTM) CEO David Meeker Disposes of 45,494 Shares

Rhythm Pharmaceuticals Inc (NASDAQ:RYTM), a biopharmaceutical company focused on the development and commercialization of therapies for the treatment of rare genetic disorders of obesity, has reported an insider sell according to a recent SEC filing. The President and CEO of the company, David Meeker, sold 45,494 shares of the company on March 19, 2024. The transaction was disclosed in an SEC Filing.

Warning! GuruFocus has detected 3 Warning Signs with RYTM.

Over the past year, the insider has sold a total of 49,855 shares and has not made any purchases of the company's stock. This latest transaction continues a trend of insider sells at Rhythm Pharmaceuticals Inc, with a total of 29 insider sells and no insider buys occurring over the past year.